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INTRODUCTION
Gastrojejunostomy or Percutaneous Endoscopic 
Gastrostomy with jejunal extension (PEG-J) is a tube 
feeding technique which allows post-pyloric deliver-
ance of nutrients or drugs. It has been used as an enter-
ic feeding technique in several clinical settings, mostly 
in PEG patients with gastro-esophageal reflux and 
high risk of respiratory aspiration and infection(2, 10), 
and occasionally in patients with acute(7) or chronic(5) 
pancreatitis. It has also been successfully used as a 
drug delivery system in severe cases of  Parkinson’s 
disease(1, 6, 8).
The gold standard for feeding palliation of  upper 
GI tract cancer is stenting the obstructed GI segment 
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ABSTRACT – Background – Stent palliation is the gold standard for gastric/duodenal cancer outlet obstruction. When stenting is impos-
sible, feeding may be achieved through a gastrojejunostomy (PEG-J), but displacement of jejunal tube is frequent due to manipulation 
for feeding and drainage. Gastric outlet obstruction results on increased gastroesophageal reflux or extra-tube leakage. In order to 
reduce the jejunostomy tube manipulation and the gastric residuum, we created a second gastrostomy (PEG) dedicated to gastric 
drainage, reducing the PEG-J handling. Objective – Our aim was evaluating of the usefulness of an added second gastrostomy in a 
PEG-J patient, for: 1. controlling symptomatic reflux and extra-tube leakage; 2. preventing jejunal tube dislocation. Methods – We 
retrospectively evaluated patients were stent palliation of gastric/duodenal cancer outlet obstruction was not achieved, who were 
referred and underwent PEG-J. We selected four of these patients who needed a second PEG dedicated to gastric drainage, which 
was performed a few centimetres apart from the gastrojejunostomy. In order to achieve an efficient gastric drainage and provide 
the maximum comfort to the patient, the drainage PEG tube could be linked to an ileostomy bag. Results – The four PEG-J cancer 
patients with longer survival developed symptoms associated with an important gastric residuum. After the drainage gastrostomy, 
symptoms subsided or vanished and there were no jejunal tube dislocations. Conclusions – When stenting is not possible in patients 
with gastric/duodenal outlet obstruction due to cancer growing, feeding PEG-J plus drainage PEG may be an alternative, allowing 
duodenal/jejunal feeding and gastric drainage with minimal manipulation of the jejunal tube.
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with a self-expanding metallic stent, allowing feeding 
with an almost normal oral diet. The use of  PEG-J 
as a tube feeding technique for palliation in upper 
GI tract malignancy has been seldom reported. To 
the best of  our knowledge, the first report of  the use 
of  PEG-J for feeding an obstructive cancer patient 
comes from a Japanese pancreatic cancer case(4). Ac-
tually, PEG-J should not be used routinely in gastric 
cancer obstruction, as it has been proved to be asso-
ciated with shorter survival and device patency then 
stent palliation(9). Nevertheless, PEG-J may be useful 
in gastric/duodenal cancer outlet obstruction when 
stenting is impossible due to technical issues or other 
reasons. These cases include gastric cancers from the 
antrum and duodenal malignancies arising from the 
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pancreas or from the duodenal wall. In these cases, feeding 
may be achieved using a PEG-J, but complications occur. 
Dislocation of  jejunal tube is frequent due to manipulation 
for feeding and gastric drainage. We have a large experience 
of  creating a gastrojejunostomy using a 24 French Kimber-
ly-Clark® gastrostomy kit and, subsequently, passing a 12 
French Bard® jejunal feeding/gastric decompressing tube 
whose distal tip is placed in the distal duodenum or in the 
jejunum. Later, as the gastrostomy fistula matures, we may 
replace this two tubes system by a single 22 French Kim-
berly-Clark® jejunal feeding tube with a gastric drainage. 
But using any of  these two all-in-one systems demands 
manipulation of  the feeding tube whenever it is necessary 
drainage of  gastric contents. Also, gastric outlet obstruc-
tion may result on an important gastric residuum, leading 
to increased gastroesophageal reflux or extra-tube leakage 
through the gastrostomy, with persistent skin lesion. In or-
der to reduce the jejunal tube manipulation and to improve 
the reduction of  gastric residuum and stasis symptoms, 
we developed a technical solution: performing a second 
endoscopy gastrostomy (PEG) and placing a PEG tube 
devoted to gastric drainage. To the best of  our knowledge, 
this technical solution is unprecedented.
The aim of our study was the retrospective evaluation of 
the usefulness of an added second gastrostomy in a PEG-J 
patient, when gastric stasis symptoms develop, namely 
symptomatic gastroesophageal reflux or extra-tube leakage 
through the gastrostomy fistula. An additional aim was the 
evaluation of  the usefulness of  this procedure in order to 
prevent jejunal tube dislocation from the small bowel into 
the stomach.
METHODS
Patients with advanced gastric antrum or duodenal ma-
lignancies, candidates for palliation with gastric/duodenal 
stents, were referred to PEG-J when stenting was also unsuit-
able. After a successful gastrojejunostomy, patients started 
continuous enteral feeding with an increasing infusion rate. 
After achieving an infusion rate of 80cc/hour, feeding was 
changed to a bolus every hour, and was gradually increased 
according with patient’s tolerance. Increasing bolus volume 
was accompanied with increasing time gaps between boluses, 
allowing the patients to live with a greater independence from 
the feeding procedure. Continuous enteral feeding infusion 
was kept during the night only if  needed to achieve patient’s 
needs. When bolus feeding balance was achieved, patients 
were discharged and followed as outpatients, initially with 
appointments on a weekly basis.
During hospitalization or after discharge, some patients 
develop stasis-associated symptoms, as reflux symptoms, 
mainly regurgitation, or extra-tube leakage causing skin le-
sions. To these patients, a second endoscopic gastrostomy is 
proposed, in order to drain the gastric residuum. This second 
gastrostomy may be performed in an outpatient basis, and 
the tube is placed a few centimetres apart from the gastro-
jejunostomy using the same stomach area, already in close 
contact with the abdominal wall (Figure 1). The drainage 
PEG tube (Figure 2) may be linked to a urine drainage bag 
or, more practical for some patients, to a skin level ileostomy 
bag. The ileostomy bag may be changed by the patient or 
caregiver. The patients kept gastrojejunostomy feeding as 
before and kept being followed as outpatients.
FIGURE 1. Endoscopic view, showing a recently placed PEG drainage 
tube side-by-side with a previous placed feeding PEG-J
FIGURE 2. Skin view, showing a recently placed PEG drainage tube side-
by-side with a previous placed feeding PEG-J. On the PEG-J, the gastric 
lumen is sealed with a dressing to prevent any manipulation
RESULTS
We performed a gastrojejunostomy in eight patients 
with malignancies causing gastric outlet obstruction, three 
cancers of the antrum and five pancreatic cancers invading 
the duodenum. These patients survived from a few days to 8 
months after the PEG-J procedure. Six of them dislocated the 
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intestinal tube to the stomach and replacement was possible 
in all of them but one, a patient with a large pancreatic cancer 
invading the duodenum. The four patients with longer sur-
vival two gastric and two pancreatic malignancies developed 
symptoms associated with stasis and an important gastric 
residuum. All of them accepted to have a second drainage 
gastrostomy, which was performed without complications. 
Regurgitation disappeared and skin lesions associated with 
extra-tube leakage greatly improved. There were no incidents 
of jejunal tube dislocations after the second PEG procedure. 
Patients and/or caregivers reported us that this option was 
easier to use them the previous two-on-one feeding and 
drainage together. Patients were able to live in their homes 
with their families and keep some social activities outside 
home using the intervals between feeding bolus. Nutrition 
and hydration were provided through the PEG-J until death. 
One of our patients lived at home during 8 months, being 
able to leave home and meet his friends at the local coffee 
shop until the last month of life.
DISCUSSION
The use of  a gastrojejunostomy as an access for post-py-
loric long term enteral nutrition has been reported in 
several clinical settings. Most frequently it is used in PEG 
patients with clinical significant gastroesophageal reflux 
and respiratory aspiration(2, 10). When reflux and aspiration 
cannot be controlled with postural procedures and phar-
macotherapy, placing a jejunal tube through the PEG and 
creating a PEG-J is the most practical approach. Usually 
acute pancreatitis episodes subsides and resolves itself  in a 
time gap too short to justify a long term intestinal feeding 
access, but PEG-J was occasionally used in this setting(7). 
Although unnecessary in most patients, PEG-J has also 
been reported in chronic pancreatitis(5). Before 2007, PEG-J 
was considered for nutrition of  cancer patients only in the 
context of  head and neck cancer, when patients displayed 
a high risk of  respiratory aspiration(3). The use of  PEG-J 
in the setting of  a digestive malignancy, in order to bypass 
the obstruction, was only reported recently(4). This lack 
of  reported experience in gastric or duodenal cancer ob-
struction may have two causes. On the one hand, stenting 
is more comfortable, was proven to be superior to PEG-J 
for nutritional palliation of gastric or duodenal obstructing 
lesions, and is achievable in most cases(9). On the other hand, 
there is always some concern about using special feeding 
procedures in patients with advanced cancer. But sometimes 
stenting is not achieved, there is a survival expectancy of 
several months, suitable social conditions, and families 
willing to take care of  patients. In these selected patients, 
PEG-J palliation allows, not only feeding but also hydra-
tion during a large period until death. Adding a drainage 
PEG to the PEG-J feeding system is more handleable for 
the patient and caregivers, reduces manipulation of  the 
intestinal tube and controls symptoms related with stasis 
of  a large gastric residuum.
CONCLUSIONS
In selected cases, when stenting is not possible in patients 
with gastric/duodenal outlet obstruction due to cancer grow-
ing, a feeding PEG-J plus drainage PEG may be a suitable 
alternative for palliation purposes, allowing duodenal/jejunal 
feeding and gastric drainage with minimal manipulation of 
the PEG-J jejunal tube.
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RESUMO – Contexto – Para a obstrução gástrica/duodenal por câncer, o tratamento paliativo de referência é a colocação de prótese expansível. Quan-
do tal não é possível, o doente pode ser paliado usando uma gastrojejunostomia (PEG-J), mas a deslocação do tubo jejunal é frequente, devido a 
manipulação para alimentação e drenagem. A obstrução pode resultar em refluxo gastroesofágico e perda de líquido extra-tubo com lesão cutânea. 
Para evitar estas complicações é possível colocar uma segunda gastrostomia (PEG) dedicada à drenagem gástrica. Objectivo – O nosso objetivo foi 
avaliar a utilidade de uma segunda gastrostomia em doentes com câncer no estômago ou duodeno alimentados por PEG-J respeitante a: 1. Controlo 
do refluxo gastroesofágico e perda de líquido gástrico extra-tubo; 2. Prevenir a deslocação do tubo jejunal. Métodos – Avaliamos retrospetivamente 
doentes submetidos a PEG-J por impossibilidade de colocação de prótese para paliação de obstrução gástrica por câncer no estômago ou duode-
no. Selecionamos os quatro que necessitaram de uma segunda PEG para drenagem gástrica, efetuada a alguns centímetros da PEG-J. Para maior 
conforto a PEG de drenagem pode ser ligada a um saco de jejunostomia. Resultados – Os quatro doentes oncológicos alimentados por PEG-J com 
maior sobrevida necessitaram de uma segunda PEG. Após a PEG de drenagem, os sintomas melhoraram ou desapareceram e, não houve qualquer 
deslocação do tubo jejunal. Conclusões – Quando não é possível a paliação por prótese de doentes com obstrução neoplásica do estômago ou duodeno, 
a paliação com uma PEG-J para alimentação e uma PEG para drenagem é uma alternativa útil, permitindo a manipulação mínima do tubo jejunal.
DESCRITORES – Gastrostomia. Jejunostomia. Obstrução da saída gástrica. Neoplasias gástricas.
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